-The Hindu Vina Mazumdar, doyenne of the Indian women's movement, architect of the epochal Report of the Committee on the Status of Women in India in post independent India, passed away in a central Delhi hospital on May 30 after a brief illness. In the introduction to her memoirs published by Zubaan in 2010, she described herself as a "women's activist", a "feminist,", a "trouble-maker", but the one she liked best was...

-The Hindu "Farming is fascinating. The only thing is that it requires continuous hard-work and devotion without any distraction" says Mr. Barun Singh, a government bank manager-turned-farmer. Mr. Barun Singh maintains a vermi-composting unit in a portion of his 10 acre land. A dairy unit is attached to the composting unit so that the cattle dung can be easily utilized for the process without much labour involvement. Waste materials like dried leaves, rotten...

Argumentative Indians are at it again! After sparring over the poverty line and the actual number of poor, India's renowned economists have fired up a fresh debate over the extent of malnutrition. In the earlier debate, the Planning Commission ‘reduced' poverty on paper disregarding NSSO and official committees, including the NCEUS, which determined that 77% Indians survived on less than Rs 20 a day. Columbia university economist Arvind Panagariya has...

-The Telegraph The sudden arrest of Amway India's top brass on Monday has focused the spotlight on the crumbling fault lines and the grey areas in the demarcation between some of the world's best-known direct selling companies and the dodgy Ponzi schemes that promise huge returns to gullible investors and have lately grabbed all the sensational headlines in Bengal. William S. Pinckney, managing director of Amway India, and two directors of the...

-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...